Extensive sequence analysis of CFTR, SCNN1A, SCNN1B, SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis-like phenotypes

The term cystic fibrosis (CF)‐like disease is used to describe patients with a borderline sweat test and suggestive CF clinical features but without two CFTR(cystic fibrosis transmembrane conductance regulator) mutations. We have performed the extensive molecular analysis of four candidate genes (SC...

Full description

Saved in:
Bibliographic Details
Published inClinical genetics Vol. 86; no. 1; pp. 91 - 95
Main Authors Ramos, M.D., Trujillano, D., Olivar, R., Sotillo, F., Ossowski, S., Manzanares, J., Costa, J., Gartner, S., Oliva, C., Quintana, E., Gonzalez, M.I., Vazquez, C., Estivill, X., Casals, T.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The term cystic fibrosis (CF)‐like disease is used to describe patients with a borderline sweat test and suggestive CF clinical features but without two CFTR(cystic fibrosis transmembrane conductance regulator) mutations. We have performed the extensive molecular analysis of four candidate genes (SCNN1A, SCNN1B, SCNN1G and SERPINA1) in a cohort of 10 uncharacterized patients with CF and CF‐like disease. We have used whole‐exome sequencing to characterize mutations in the CFTR gene and these four candidate genes. CFTR molecular analysis allowed a complete characterization of three of four CF patients. Candidate variants in SCNN1A, SCNN1B, SCNN1G and SERPINA1 in six patients with CF‐like phenotypes were confirmed by Sanger sequencing and were further supported by in silico predictive analysis, pedigree studies, sweat test in other family members, and analysis in CF patients and healthy subjects. Our results suggest that CF‐like disease probably results from complex genotypes in several genes in an oligogenic form, with rare variants interacting with environmental factors.
Bibliography:ESGI - No. 262055
ark:/67375/WNG-XHW4WZ8V-J
Federación Española de FQ
istex:0C48952DAA6259DEE17E8D8CF2DC490185A83014
GEUVADIS - No. 261123
Instituto de Salud Carlos III - No. FIS/FEDER PI11/00733
Spanish Ministry of Economy and Competiveness
Table S1. Cystic fibrosis transmembrane conductance regulator (CFTR) comparative analysis and the corroborated selected variants identified by exome sequencing in the 10 samples analyzed.Table S2. Allelic frequencies of the epithelial sodium channel (ENaC) variants in cystic fibrosis (CF)-like patients and two control groups.Table S3. Sequencing and coverage statistics for the candidate genes in the 10 samples [cystic fibrosis (CF) and CF-like].Table S4. All single nucleotide variants (SNVs) detected by exome analysis in the ten samples included in this study.Table S5. Insertion/deletion variants detected by the exome analysis in the 10 samples included in this study.Figure S1. Genomic structure of genes encoding the epithelial sodium channel (ENaC) subunits and location of the different variants corroborated after the exome sequencing.Figure S2. Flowchart of the bioinformatics pipeline used in the analysis of whole-exome data.
Generalitat de Catalunya - No. AGAUR 2009 SGR-1502
ArticleID:CGE12234
Spanish Plan Nacional (NOVADIS) - No. SAF2008-00357
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0009-9163
1399-0004
1399-0004
DOI:10.1111/cge.12234